Covid 19 Impact On, Narcolepsy Drugs Market 2018 Growth, Demands, CAGR, Sales Volume, Opportunities, Latest Market Dynamics and Forecast Up to 2028
The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques.
To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068
Moreover, constant development of promising pharmacological treatment options has generated attention in the disease treatment among the research community and care-givers in various parts of the world. Marked prevalence rate of the sleep disorder in numerous countries and growing numbers of patients witnessing comorbid conditions have fueled the expansion of the narcolepsy drugs market. Growing body of clinical trials of narcolepsy drugs in animal models as well as in humans has helped the drug pipeline lucrative in the narcolepsy drugs market.
Global Narcolepsy Drugs Market: Key Drivers
An array of therapies including drug treatment of narcolepsy have been successful only in symptomatic control of the disorder. The narcolepsy market has seen growing numbers of drugs for relieving daytime sleepiness symptoms and antidepressants for cataplexy. Narcolepsy patients witnessing cataplexia may suffer traumatic events, pressing the need for more efficacious drugs whose focus extend beyond symptom control.
In recent years, substantial focus has been given on testing the effectiveness of narcolepsy drugs that contain wake-promoting agents. Additionally, anticataplectic agents have gathered traction in the narcolepsy drugs market. In particular, hypocretin-based therapy has shown vast potential in narcolepsy treatment; albeit clinical developments have been very limited. In future, direct intranasal administration of orexin peptides might prove to be potentially effective in treating narcolepsy. This might change the directions of the narcolepsy drugs market in the not-so-distant future. Numerous neurochemical studies in animals have furthered the potential. Hypocretin replacement strategies may also show the way, but are far-fetched. The advent of better-tolerated compounds may open new avenues in the narcolepsy drugs market.
Global Narcolepsy Drugs Market: Notable Developments
In recent years, growing numbers of drugs approved by U.S. Food and Drug Administration (FDA) which have proved effective in relieving patients of narcolepsy symptoms underscore the aforementioned trend. For instance, in early 2019, the U.S. FDA approved first dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI)—solriamfetol—to treat symptom of excessive daytime sleepiness in adult patients. The novel mechanism of action of solriamfetol was validated in several clinical studies spanning 12-week. Of note, the biopharmaceutical company Jazz Pharmaceuticals expects the narcolepsy drug to be available commercially in the U.S. in the next few years.
In another promising drug development, Avadel Pharmaceuticals, announced in September 2019 that it has got the nod from the U.S. FDA to its proposed amendments in plan and protocol the company has been employing in developing once-nightly sodium oxybate. The FDA has accepted the company’s recommendation to downsize the sample—it intends to include just 205 patients—for validating significance of its narcolepsy drug for both excessive daytime sleepiness and cataplexy. The enrolment will end tentatively by this year-end.
Such favorable regulatory impetus will expedite new drug development in the nacrlepsy drugs market. The drug called Once-nightly FT218 has already been approved by the agency to be used as an orphan drug for narcolepsy. The biopharmaceutical company has pinned large hopes on FT218, which if approved, will help it strengthen its hold in the narcolepsy drugs market.
Global Narcolepsy Drugs Market: Regional Assessment
Among the various regions, Asia Pacific has shown large potential and is anticipated to rise at rapid growth rate from 2019 to 2028. The large unmet need in the regional population will help in its evolution. Large prevalence of sleeping disorders has fueled the demand for narcolepsy drugs in the region. On the other side, extensive research on developing new therapies in the U.S. has kept the North America narcolepsy drugs market increasingly lucrative.
Request TOC of the Report for more Industry Insights @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6068
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in today’s supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Covid 19 Impact On, Narcolepsy Drugs Market 2018 Growth, Demands, CAGR, Sales Volume, Opportunities, Latest Market Dynamics and Forecast Up to 2028 here
News-ID: 2170299 • Views: 124
More Releases from TMR Research
Recycled Thermoplastic Market Insights By Growth, Emerging Trends And Forecast B …
Recycled Thermoplastic Market: Snapshot The demand within the global recycled thermoplastic market has been rising on account of advancements in the energy sector. The use of thermoplastics across a wide array of industries has given a thrust to the growth of the global market. Moreover, the superiority of recycled thermoplastics over thermosets has also given a strong push to the growth of the global market. There have been key advancements in
Smart Card Materials Market Projected to Witness a Double-Digit CAGR During 2028
Global Smart Card Materials Market: Snapshot The global market smart card has gained phenomenal momentum in recent years due to increasing usage of smart cards in various industries for various purposes. The growing popularity of smart cards due to the convenience they offer for identification, cashless payments, and tracking amongst other things. Proliferation of BFSI industry that has seen a constant rise in its consumer base has prompted many smart card
Taxifolin Market Dynamic Business Environment During Forecast 2018 – 2028
Taxifolin Market: Snapshot Taxifolin or dihydroquercetin is a flavonoid that acts as a potential chemopreventive agent. It helps in the regulation of genes through an ARE-dependent mechanism. Primarily, taxifolin has the properties to slow down the cell growth of ovarian cancer. It can be found across many products and beverages. Particularly, taxifolin can be found across plant-based foods such as vegetables, wine, cocoa, and fruits. Conifers such as Siberian larch and
Nafion Market Promising Growth Opportunities & Forecast 2019-2029
Nafion Market: Snapshot Nafion is a sophisticated name for sulfonated tetrafluoroethylene based fluoropolymer-copolymer. It was first discovered by Walter Grot of DuPont back in the 1960s. Nafion is a first synthetic polymer that possesses ionic properties that are known as ionomers. Nafion has unique ionic features because of the incorporation of perfluorovinyl ether groups with terminated sulfonate groups onto a PTFE backbone. Nafion can also act as a cation exchange polymer
More Releases for Narcolepsy
A Comprehensive Study exploring Narcolepsy Therapeutics Market
A new research study from HTF MI with title Global Narcolepsy Therapeutics Market Size, Status and Forecast 2025 provides an in-depth assessment of the Narcolepsy Therapeutics including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Narcolepsy Therapeutics investments till 2025. Access Sample Copy @: https://www.htfmarketreport.com/sample-report/1181484-global-narcolepsy-therapeutics-market-4 If you are involved in the Narcolepsy Therapeutics industry or intend
Narcolepsy Market entry and market expansion strategies
MarketResearchReports.Biz adds “Global Narcolepsy Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Narcolepsy and the growth estimates for the forecasted period. GlobalData's clinical trial report, Narcolepsy Global Clinical Trials Review, H1, 2018" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of
Narcolepsy Treatment Pipeline Review H2 2017
Pune, India, 26th October 2017: WiseGuyReports announced addition of new report, titled “Narcolepsy - Pipeline Review, H2 2017”. Summary Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics
Narcolepsy Market Pipeline Review, H2 2017
"The Report Narcolepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime
Narcolepsy Drug Market Size 2017-2022 Novartis, Mylan, Teva Pharmaceutical
In the last several years, global market of narcolepsy drug developed rapidly, with an average growth rate of 9.6%. In 2016, global revenue of narcolepsy drug is nearly 1725 M USD; the actual production is about 48380 Kg. The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will
Narcolepsy - Pipeline Review, H1 2017 - Pharmaceutical Report
Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068443 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Narcolepsy (Central Nervous System), complete